Home > Acronyms and Abbreviations -...

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Ratko TA, Belinson SE, Brown HM, et al. Hematopoietic Stem-Cell Transplantation in the Pediatric Population [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Feb. (Comparative Effectiveness Reviews, No. 48.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Acronyms and Abbreviations

aGVHD

acute graft vs. host disease

AHRQ

Agency for Healthcare Research and Quality

AIHA

autoimmune hemolytic anemia

ALCL

anaplastic large cell lymphoma

ALL

acute lymphoblastic leukemia

Allo

allogeneic

AML

acute myelogenous leukemia

ASBMT

American Society for Blood and Marrow Transplantation

AT/ RT

atypical teratoid/rhabdoid tumor

ATG

antithymocyte globulin

Auto

autologous

BAALC

brain and acute leukemia, cytoplasmic

BL

Burkitt-like

BMF

bone-marrow failure

BMT

bone-marrow transplant

CAMT

congenital amegakaryocytic thrombocytopenia

CC

calcinosis cutis

C-CSF

granulocyte colony-stimulating factor

CD

Crohn's disease

CDAI

Crohn's disease activity index

CDC

Centers for Disease Control and Prevention

cGVHD

chronic graft vs. host disease

CI

confidence interval

CIBMTR

Center for International Bone Marrow Transplant Research

CML

chronic myelogenous leukemia

CNS

central nervous system

COCALD

childhood onset of cerebral adrenoleukodystrophy

COG

Children's Oncology Group

CR

complete remission

Cy

cyclophosphamide

DAI

disease activity index

DBA

Diamond Blackfan anemia

DFS

disease-free survival

DFS

disease-free survival

DLBCL

diffuse large B-cell lymphoma

DM

diabetes mellitus

DQ

developmental quotient

DOD

dead of disease

DOT

dead of treatment

EBMT

European Group for Blood and Marrow Transplantation

EDSS

expanded disability status scale

EFS

event-free survival

EPC

Evidence-based Practice Center

ERT

enzyme-replacement therapy

ES

Evans syndrome

ESFT

Ewing sarcoma family of tumors

F

female

FA

Fanconi anemia

FFS

failure-free survival

Flu

fludarabine

GCT

germ-cell tumor

GFR

glomerular filtration rate

GI

gastrointestinal

GVHD

graft versus host disease

GVM

graft versus malignancy

Hb

hemoglobin

HbF

fetal hemoglobin

HDC

high-dose chemotherapy

HL

Hodgkin's lymphoma

HLA

human leukocyte antigen

HR

hazard ratio

HSCT

hematopoietic stem-cell transplant

HU

hydroxyurea

ICGG

International Collaborative Gaucher Group

IIT

intensive insulin therapy

IPI

international prognostic index

IQ

intelligence quotient

IVIG

intravenous immune globulin

JIA

juvenile idiopathic arthritis

JCML

juvenile chronic myelogenous leukemia

JMML

juvenile myelomonocytic leukemia

JRA

juvenile rheumatoid arthritis

KQ

Key Question(s)

L&H

lymphocytic and histiocytic

LBL

lymphoblastic lymphoma

LCL

large-cell lymphoma

LDH

lactate dehydrogenase

LFS

leukemia-free survival

LL

lymphoblastic lymphoma

M

male

MA

meta analysis

MALT

mucosa-associated lymphoid tissue

MDS

myelodysplastic syndrome

MG

myasthenia gravis

MLD

metachromatic leukodystrophy

Mo(s).

month(s)

MPS

mucopolysaccharidosis

MRD

matched related donor

MRD

minimal residual disease

MRI

magnetic resonance imaging

MSC

mesenchymal stem cells

MS

multiple sclerosis

MSD

matched sibling donor

MUD

matched unrelated donor

N, n

number

NA

not applicable

NB

neuroblastoma

NCCN

National Comprehensive Cancer Network

NHL

non-Hodgkin's lymphoma

NHLBI

National Heart, Lung, and Blood Institute

NK

natural killer

NOS

not otherwise specified

NR

not reported

OS

osteosarcoma

OS

overall survival

OS

overlap syndrome

PBSC

peripheral blood stem cells

PBSCT

peripheral blood stem-cell transplant

PDQ®

Physician Data Query

PFS

progression-free survival

Ph+/-

Philadelphia chromosome positive/negative

PICOTS

patients, interventions, comparator, outcomes, timing, setting

PNET

primitive neuroectodermal tumor

PPMS

primary progressive multiple sclerosis

PR

partial remission

PRMS

progressive relapsing multiple sclerosis

Pt(s)

patient(s)

PTCL

peripheral T-cell lymphoma

QOL

quality of life

RA

refractory anemia

RAEB

refractory anemia with excess blasts

RCT

randomized, controlled trial

RMS

rhabdomyosarcoma

RR

relative risk

RRMS

relapsing, remitting multiple sclerosis

RuSH

Registry and Surveillance System in Hemoglobinopathies

sAML

secondary acute myelogenous leukemia

SCD

sickle-cell disease

SCID

severe combined immunodeficiency

SCIG

subcutaneous immune globulin

SCN

severe congenital neutropenia

SCT

stem-cell transplant

SDS

Schwachman Diamond syndrome

SE

standard error

SLE

systemic lupus erythematosus

SLEDAI

Systemic Lupus Erythematosus Disease Activity Index

SPMS

secondary progressive multiple sclerosis

SS

systemic sclerosis

SSc

systemic sclerosis

TBI

total body irradiation

TEC

Technology Evaluation Center

TEP

Technical Expert Panel

TFS

thalassemia-free survival

TKI

tyrosine kinase inhibitor

TNF

tumor necrosis factor

TRM

treatment-related mortality

Tx

treatment/therapy

UCB

umbilical cord blood

URD

unrelated donor

VEGF

vascular endothelial growth factor

VLCFA

very long chain fatty acids

VOD

veno-occlusive disease

WBC

white blood cell

WT

Wilms tumor

Yr(s)

year(s)

Cover of Hematopoietic Stem-Cell Transplantation in the Pediatric Population
Hematopoietic Stem-Cell Transplantation in the Pediatric Population [Internet].
Comparative Effectiveness Reviews, No. 48.
Ratko TA, Belinson SE, Brown HM, et al.

AHRQ (US Agency for Healthcare Research and Quality)

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...